ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2) von Cardoso, F., Costa, A., Norton, L., Senkus, E., Aapro, M., André, F., Barrios, C.H., Bergh, J., Biganzoli, L., Blackwell, K.L., Cardoso, M.J., Cufer, T., El Saghir, N., Fallowfield, L., Fenech, D., Francis, P., Gelmon, K., Giordano, S.H., Gligorov, J., Goldhirsch, A., Harbeck, N., Houssami, N., Hudis, C., Kaufman, B., Krop, I., Kyriakides, S., Lin, U.N., Mayer, M., Merjaver, S.D., Nordström, E.B., Pagani, O., Partridge, A., Penault-Llorca, F., Piccart, M.J., Rugo, H., Sledge, G., Thomssen, C., van't Veer, L., Vorobiof, D., Vrieling, C., West, N., Xu, B., Winer, E.

Volltext

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2) von Cardoso, F, Costa, A, Norton, L, Senkus, E, Aapro, M, André, F, Barrios, C.H, Bergh, J, Biganzoli, L, Blackwell, K.L, Cardoso, M.J, Cufer, T, El Saghir, N, Fallowfield, L, Fenech, D, Francis, P, Gelmon, K, Giordano, S.H, Gligorov, J, Goldhirsch, A, Harbeck, N, Houssami, N, Hudis, C, Kaufman, B, Krop, I, Kyriakides, S, Lin, U.N, Mayer, M, Merjaver, S.D, Nordström, E.B, Pagani, O, Partridge, A, Penault-Llorca, F, Piccart, M.J, Rugo, H, Sledge, G, Thomssen, C, van’t Veer, L, Vorobiof, D, Vrieling, C, West, N, Xu, B, Winer, E

Volltext

Data from the EORTC Cancer Survivorship Task Force von Vrieling, C, Moser, L, Liu, L, Meunier, F

Volltext

1BA The impact of pathological factors on long-term local control in the EORTC boost no-boost trial von Vrieling, C, Van Werkhoven, E, Poortmans, P, Struikmans, H, Weltens, C, Fourquet, A, Jager, J, Schinagl, D, Collette, L, Maingon, P, Bartelink, H

Volltext

Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients? von Vrieling, C, Collette, L, Fourquet, A, Hoogenraad, W.J, Horiot, J.-C, Jager, J.J, Bing Oei, S, Peterse, H.L, Pierart, M, Poortmans, P.M, Struikmans, H, Van den Bogaert, W, Bartelink, H

Volltext

Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial von Bartelink, Harry, Dr, Maingon, Philippe, MD, Poortmans, Philip, MD, Weltens, Caroline, MD, Fourquet, Alain, MD, Jager, Jos, MD, Schinagl, Dominic, MD, Oei, Bing, MD, Rodenhuis, Carla, MD, Horiot, Jean-Claude, MD, Struikmans, Henk, MD, Van Limbergen, Erik, MD, Kirova, Youlia, MD, Elkhuizen, Paula, MD, Bongartz, Rudolf, MD, Miralbell, Raymond, MD, Morgan, David, MD, Dubois, Jean-Bernard, MD, Remouchamps, Vincent, MD, Mirimanoff, René-Olivier, MD, Collette, Sandra, MSc, Collette, Laurence, PhD

Volltext

EP-1831 Avoidance sector strategy to reduce healthy tissue dose in locoregional breast planning with VMAT von Thengumpallil, S., Bezard, J., Spruijt, K.H., Peguret, N., Vrieling, C.

Volltext

230 - Data from the EORTC Cancer Survivorship Task Force von Vrieling, C., Moser, L., Liu, L., Meunier, F.

Volltext

Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer – A study based on the EORTC trial 22881–10882 ‘boost versus no boost’... von Collette, Sandra, Collette, Laurence, Budiharto, Tom, Horiot, Jean-Claude, Poortmans, Philip M, Struikmans, Henk, Van den Bogaert, Walter, Fourquet, Alain, Jager, Jos J, Hoogenraad, Willem, Mueller, Rolf-Peter, Kurtz, John, Morgan, David A.L, Dubois, Jean-Bernard, Salamon, Emile, Mirimanoff, Rene, Bolla, Michel, Van der Hulst, Marleen, Wárlám-Rodenhuis, Carla C, Bartelink, Harry

Volltext

The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC ‘boost vs. no boost’ trial von Vrieling, Conny, Collette, Laurence, Fourquet, Alain, Hoogenraad, Willem J., Horiot, Jean-Claude, Jager, Jos J., Pierart, Marianne, Poortmans, Philip M., Struikmans, Henk, Maat, Ben, Van Limbergen, Erik, Bartelink, Harry

Volltext

Impact of a boost of 16 Gy on local control in patients with early stage breast cancer older than 50 years of age von Vrieling, C

Volltext

O-18 Is face-view only enough for the aesthetic evaluation of breast cancer conservative treatment (BCCT)? von Cardoso, M.J, Cardoso, J.S, Vrieling, C, Christie, D, Joahensen, J, Costa, S, Almeida, T

Volltext

The influence of the boost in breast-conserving therapy on cosmetic outcome in the eortc “boost versus no boost” trial von Vrieling, Conny, Collette, Laurence, Fourquet, Alain, Hoogenraad, Willem J., Horiot, Jean-Claude, Jager, Jos J., Pierart, Marianne, Poortmans, Philip M., Struikmans, Henk, Van der Hulst, Marleen, Van der Schueren, Emmanuel, Bartelink, Harry

Volltext

Validation of the methods of cosmetic assessment after breast-conserving therapy in the EORTC “boost versus no boost” trial von Vrieling, Conny, Collette, Laurence, Bartelink, Ellen, Borger, Jacques H., Brenninkmeyer, Stefan J., Horiot, Jean-Claude, Pierart, Marianne, Poortmans, Philip M., Struikmans, Henk, Van der Schueren, Emmanuel, Van Dongen, Joop A., Van Limbergen, Erik, Bartelink, Harry

Volltext

Posterior interosseous nerve syndrome: literature review and report of 14 cases von Vrieling, C., Robinson, P. H., Geertzen, J. H. B.

Volltext

Anterior interosseous nerve syndrome: literature review and report of 11 cases von Vrieling, C., Robinson, P. H., Geertzen, J. H. B.

Volltext

The value of 3D images in the aesthetic evaluation of breast cancer conservative treatment. Results from a prospective multicentric clinical trial von Cardoso, MJ, Vrieling, C, Cardoso, JS, Oliveira, HP, Williams, NR, Dixon, JM, PICTURE Project Clinical Trial Team, PICTURE Project Delphi Panel

Volltext bestellen

The influence of the boost in breast-conserving therapy on cosmetic outcome in the EORTC "boost versus no boost" trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. Eur... von Vrieling, C, Collette, L, Fourquet, A, Hoogenraad, W J, Horiot, J C, Jager, J J, Pierart, M, Poortmans, P M, Struikmans, H, Van der Hulst, M, Van der Schueren, E, Bartelink, H

Volltext

Validation of the methods of cosmetic assessment after breast-conserving therapy in the EORTC "boost versus no boost" trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups... von Vrieling, C, Collette, L, Bartelink, E, Borger, J H, Brenninkmeyer, S J, Horiot, J C, Pierart, M, Poortmans, P M, Struikmans, H, Van der Schueren, E, Van Dongen, J A, Van Limbergen, E, Bartelink, H

Volltext

The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC 'boost vs. no boost' trial. EORTC Radiotherapy and Breast... von Vrieling, C, Collette, L, Fourquet, A, Hoogenraad, W J, Horiot, J H, Jager, J J, Pierart, M, Poortmans, P M, Struikmans, H, Maat, B, Van Limbergen, E, Bartelink, H

Volltext